Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription 25.08.2025 3 Acta Psychiatr Scand 2 Biol Psychiatry 1 Br J Psychiatry 2 J Clin Psychopharmacol 1 Mol Psychiatry 2 Neuropsychopharmacology 1 PLoS One 5 Psychiatry Res 2 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. VAURIO O, Tiihonen J, Lahteenvuo M, Lieslehto J, et al
   Psychopathic Traits Associate With Later Schizophrenia.
   Acta Psychiatr Scand. 2025 Aug 25. doi: 10.1111/acps.70027.
   PubMed         Abstract available
   
   
2. NORMARK S, Wium-Andersen MK, Osler M, Wium-Andersen IK, et al
   Risk of Dementia in Patients Suffering From Psychosis-A Danish Register-Based Cohort Study.
   Acta Psychiatr Scand. 2025;152:180-186.
   PubMed         Abstract available
   
   
3. TAYLOR D, Gee S, Helthuis M, Oloyede E, et al
   The Safety of 12-Weekly Monitoring of Neutrophil Count in Long-Term Clozapine Patients.
   Acta Psychiatr Scand. 2025;152:187-192.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

4. MOLLON J, Schultz LM, Knowles EEM, Jacquemont S, et al
   Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility.
   Biol Psychiatry. 2025;98:476-484.
   PubMed         Abstract available
   
   
5. WANG SH, Feng YA, Lin MC, Cheng CF, et al
   Incorporating Polygenic Liability and Family History for Predicting Psychiatric Diseases in the Taiwan Biobank.
   Biol Psychiatry. 2025;98:485-493.
   PubMed         Abstract available
   
   

   
   Br J Psychiatry

6. DE PERI L, Mellacqua ZB
   The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, De Peri et al.
   Br J Psychiatry. 2025 Aug 19:1. doi: 10.1192/bjp.2025.10370.
   PubMed        
   
   

   
   J Clin Psychopharmacol

7. PIRES AC, Faria I, Bajouco M, Mota D, et al
   Clozapine-Resistant Schizophrenia and Wolff-Parkinson-White Syndrome: A Case Report.
   J Clin Psychopharmacol. 2025 Aug 22. doi: 10.1097/JCP.0000000000002055.
   PubMed        
   
   
8. JOHN AP, Prajapati H, Dragovic M
   Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine.
   J Clin Psychopharmacol. 2025 Aug 15. doi: 10.1097/JCP.0000000000002058.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

9. WAKUDA T, Yokokura M, Magata Y, Suzuki C, et al
   alpha7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study.
   Mol Psychiatry. 2025 Aug 19. doi: 10.1038/s41380-025-03162.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

10. ANKEETA A, Tripathi A, Pillai B, Ma Y, et al
    Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia.
    Neuropsychopharmacology. 2025 Aug 23. doi: 10.1038/s41386-025-02204.
    PubMed         Abstract available
    
    
11. KU BS, Young JW
    Social environment as a determinant of mismatch negativity in early psychosis.
    Neuropsychopharmacology. 2025 Aug 19. doi: 10.1038/s41386-025-02195.
    PubMed        
    
    

    
    PLoS One

12. GUO Y, Wu J, Lei X, Zhang H, et al
    The relationship between sarcopenic obesity and cognitive functionality among inpatients with stable schizophrenia.
    PLoS One. 2025;20:e0330453.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

13. BLAIN SD, Kent JS, Peyromaure de Bord CA, Sponheim SR, et al
    Social cognitive deficits in schizophrenia, bipolar disorder, and first-degree relatives: A large-sample, multi-task investigation.
    Psychiatry Res. 2025;352:116694.
    PubMed         Abstract available
    
    
14. BIAGETTI R, Caiazza L, Giuva T, Pirani G, et al
    Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report.
    Psychiatry Res. 2025;351:116646.
    PubMed         Abstract available
    
    
15. GOMBAS SA, Moran EK, Barch DM
    Relationships between cognition and symptoms across mood and psychotic disorders.
    Psychiatry Res. 2025;351:116628.
    PubMed         Abstract available
    
    
16. ZHU T, Jiao X, Zhou J, Nicholas PJ, et al
    Efficacy of rTMS on SCZ symptoms: Insights from connectome mapping.
    Psychiatry Res. 2025;351:116568.
    PubMed         Abstract available
    
    
17. JUST SA, Elvevag B, Pandey S, Nenchev I, et al
    Moving beyond word error rate to evaluate automatic speech recognition in clinical samples: Lessons from research into schizophrenia-spectrum disorders.
    Psychiatry Res. 2025;352:116690.
    PubMed         Abstract available
    
    

    
    Psychol Med

18. MUKHTAR H, Zhou D, Farina EA, Saxena A, et al
    Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis.
    Psychol Med. 2025;55:e241.
    PubMed         Abstract available
    
    
19. SUN T, Zhu Y, Zhao P, Zhao W, et al
    Impact of schizophrenia-associated risk genes on brain functional networks and executive deficits: a study of individuals with schizophrenia and genetic high risk.
    Psychol Med. 2025;55:e240.
    PubMed         Abstract available
    
    

    
    Schizophr Res

20. NIU Z, Jia L, Tian L, Liu Y, et al
    Evaluating the abnormal neural variability in schizophrenia: A TMS-EEG study.
    Schizophr Res. 2025;284:214-221.
    PubMed         Abstract available
    
    
21. KITTLESON AR, Woodward ND, McHugo M, Liu J, et al
    A two-year longitudinal investigation of insula subregional cortical thickness and surface area in early psychosis.
    Schizophr Res. 2025;284:204-213.
    PubMed         Abstract available
    
    
22. HUMBLE MB, Mobarrez F, Eklund D, Bejerot S, et al
    Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines.
    Schizophr Res. 2025;284:195-203.
    PubMed         Abstract available
    
    
23. EMPSON LA, Golay P, Baumann PS, Favrod J, et al
    Refining targets for urban remediation in early psychosis.
    Schizophr Res. 2025;284:186-194.
    PubMed         Abstract available
    
    
24. BADENOCH JB, Rickards H, McCutcheon RA, Nair A, et al
    Psychosis in Huntington's disease: a review and comparison with schizophrenia.
    Schizophr Res. 2025;284:175-185.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.